Asthma: A Multidisciplinary Approach, 2C (Clinics Collections)

Name: Asthma: A Multidisciplinary Approach, 2C (Clinics Collections)
Brand: Elsevier
Price: 36.99 EUR
Availability: OnlineOnly

Joel J. Heidelbaugh(Autor*in)

Elsevier (Verlag)

1. Auflage

Erschienen am 18. September 2015

100 Seiten

E-Book

ePUB mit Adobe-DRM

Systemvoraussetzungen

978-0-323-35960-3 (ISBN)

36,99 €inkl. 7% MwSt.

Systemvoraussetzungen

für ePUB mit Adobe-DRM

E-Book Einzellizenz

Als Download verfügbar

Beschreibung

Weitere Details

Weitere Ausgaben

Inhalt

Front Cover
Asthma: A Multidisciplinary Approach
Copyright Page
Table of Contents
Contributors
Preface
Chapter 1. What is Asthma? Pathophysiology, Demographics, and Health Care Costs
WHAT IS ASTHMA?
PATHOPHYSIOLOGY
DEMOGRAPHICS AND EPIDEMIOLOGY
SUMMARY
REFERENCES
Chapter 2. Asthma: A Chronic Infectious Disease?
INTRODUCTION
DUAL ROLE OF INFECTIONS IN THE ETIOLOGY OF ASTHMA
INFECTIONS PROTECT FROM THE DEVELOPMENT OF ASTHMA
RESPIRATORY INFECTIONS AND INCREASED RISK OF DEVELOPMENT OF ASTHMA
RESPIRATORY VIRAL INFECTIONS AND INCREASED RISK OF DEVELOPMENT OF ASTHMA
RSV INFECTIONS AND INCREASED RISK OF DEVELOPMENT OF ASTHMA
RV INFECTIONS OF THE RESPIRATORY TRACT AND INCREASED RISK OF DEVELOPMENT OF ASTHMA
BACTERIAL INFECTIONS AND INCREASED RISK OF DEVELOPMENT OF ASTHMA
SUMMARY
ACKNOWLEDGMENTS
REFERENCES
Chapter 3. Biomarkers in Asthma: A Real Hope to Better Manage Asthma
THE CLINICAL NEED FOR BIOMARKERS TO INFORM THE CARE OF PATIENTS WITH ASTHMA
THE EOSINOPHILIC OR T-HELPER TYPE 2 HIGH INFLAMMATION PHENOTYPE: SPUTUM EOSINOPHILS, URINARY 3-BROMOTYROSINE, AND PERIOSTIN
THE REDUCING-OXIDIZING IMBALANCE PHENOTYPE: LIPID OXIDATION AND LOSS OF ANTIOXIDANT SUPEROXIDE DISMUTASE
THE LOW PH PHENOTYPE
AIRWAY REMODELING PHENOTYPE: AIRWAY ANGIOGENIC BIOMARKERS
THE ARGININE/NO PHENOTYPE: FENO, ARGINASE, METHYLARGININES
THE LEUKOTRIENE PHENOTYPE: LEUKOTRIENE E4, LIPOXINS AND PROTECTANTS
ADDITIONAL CONSIDERATIONS FOR FUTURE STUDY
SUMMARY
REFERENCES
Chapter 4. Asthma Diagnosis in Otolaryngology Practice: Pulmonary Function Testing
PEAK FLOW MEASUREMENT
PULMONARY FUNCTION TESTING
SUMMARY
REFERENCE
Chapter 5. Asthma Diagnosis and Management
EPIDEMIOLOGY
PATHOPHYSIOLOGY
HISTORY AND PHYSICAL EXAMINATION
DIFFERENTIAL DIAGNOSIS
ED EVALUATION
TREATMENT
ß2-AGONISTS
ANTICHOLINERGICS
CORTICOSTEROIDS
MAGNESIUM SULFATE
HELIOX
LEUKOTRIENE MODIFIERS
IMMUNOTHERAPY
METHYLXANTHINES
CROMOLYN SODIUM AND NEDOCROMIL
MANAGEMENT OF STATUS ASTHMATICUS
NONINVASIVE VENTILATION
INTUBATION AND MECHANICAL VENTILATION
ASTHMA AND PREGNANCY
DISPOSITION
SUMMARY
REFERENCES
Chapter 6. Stepwise Treatment of Asthma
CRITICAL CHANGES IN THE THIRD REVISION
STEPPING THROUGH THE PROCESS OF STEPWISE CARE
SUMMARY
REFERENCES
Chapter 7. Asthma Pharmacotherapy
INTRODUCTION
BETA-2 AGONISTS
ANTICHOLINERGICS
CORTICOSTEROIDS
LEUKOTRIENE MODIFIERS
THEOPHYLLINE
MAST CELL STABILIZERS
ANTI-IMMUNOGLOBULIN E THERAPY
SPECIFIC IMMUNOTHERAPY
FUTURE THERAPY
SUMMARY
REFERENCES
Chapter 8. A Guideline-based Approach to Asthma Management
INTRODUCTION
CASE STUDY
SEVERITY
CONTROL
GUIDELINE IMPLEMENTATION
REFERENCES
Chapter 9. A Systematic Review of Complementary and Alternative Medicine for Asthma Self-management
INTRODUCTION AND BACKGROUND
METHODS
STUDY FINDINGS
SUMMARY
REFERENCES
Chapter 10. Corticosteroids: Still at the Frontline in Asthma Treatment?
INTRODUCTION
FROM EARLY PROMISE TO THE TIME OF CERTITUDE
CORTICOSTEROIDS AND LOSS OF LUNG FUNCTION
THE RECOGNITION OF REFRACTORY ASTHMA
THE MOLECULAR CONCEPT OF CORTICOSTEROID RESISTANCE
COMPLEMENTARY TREATMENT TO CORTICOSTEROIDS IN REFRACTORY ASTHMA
EMERGENCE OF THE CONCEPT OF ASTHMA PHENOTYPE IN MILD TO MODERATE ASTHMA
PREDICTING FACTORS OF CLINICAL RESPONSE TO CORTICOSTEROIDS
CORTICOSTEROIDS IN CLINICAL PRACTICE
NEW CLASS DRUG IN DEVELOPMENT
SUMMARY
ACKNOWLEDGMENTS
REFERENCES
Chapter 11. Childhood Asthma: Considerations for Primary Care Practice and Chronic Disease Management in the Village of Care
INTRODUCTION
QUESTION 1: WHY DOES THIS RELATE TO MY PRACTICE AND THE CARE I PROVIDE
QUESTION 2: WHY SHOULD WE USE CHILDHOOD ASTHMATO CONSIDER A MODEL OF ADVANCED PRIMARY CARE
QUESTION 3: WHY IS IT IMPORTANT TO CONTROL CHILDHOOD ASTHMA
QUESTION 4: WHY HAS IT BEEN DIFFICULT TO CONTROL CHILDHOOD ASTHMA
QUESTION 5: HOW DOES THE AFFORDABLE CARE ACT APPLY TO THESE CONSIDERATIONS FOR CHILDHOOD ASTHMA AND CHRONIC DISEASE CARE
QUESTIONS 6 AND 7: WHAT IS THE IMPORTANCE OF CHILDHOOD ASTHMA IN THE CONTEXT OF THE CHRONIC CARE MODEL AND HOW DO WE REACH THOSE WHO CANNOT BE REACHED
QUESTION 8: WHAT HAVE WE LEARNED FROM COMMUNITY COALITION EXAMPLES TO ADDRESS THE BURDEN OF CHILDHOOD ASTHMA
QUESTION 9: HOW DO THESE EXPERIENCES WITH LARGE COMMUNITY COALITIONS RELATE TO DEVELOPING INTEGRATED PRACTICE AND COMMUNITY-BASED APPROACHES IN A LOCAL COMMUNITY ON A SMALLER SCALE
QUESTION 10: HOW DO WE LINK COMMUNITY-BASED APPROACHES WITH PRACTICE-BASED APPROACHES TO CARE
SUMMARY
ACKNOWLEDGMENTS
REFERENCES
Chapter 12. Childhood Asthma: A Guide for Pediatric Emergency Medicine Providers
INTRODUCTION
PREVALENCE
BURDEN OF DISEASE
PATHOPHYSIOLOGY
HISTORY
PHYSICAL EXAMINATION
ASTHMA SCORES
DIFFERENTIAL DIAGNOSIS
DIAGNOSTIC EVALUATION
MANAGEMENT
OXYGEN
SABAS
SYSTEMIC CORTICOSTEROIDS
IPRATROPIUM BROMIDE
IV FLUIDS
MAGNESIUM SULFATE
IV BETA AGONIST
LEUKOTRIENE RECEPTOR ANTAGONISTS
HELIOX
NONINVASIVE MECHANICAL VENTILATION
INTUBATION
DISPOSITION
SUMMARY
REFERENCES
Chapter 13. Management of Pediatric Asthma at Home and in School
ASTHMA IN THE HOME
CASE MANAGEMENT
HOME INTERVENTIONS--ENVIRONMENT AND EDUCATION
PSYCHOSOCIAL/QUALITY OF LIFE
ASTHMA IN THE SCHOOL
SUMMARY
REFERENCES
Chapter 14. Difficult Childhood Asthma: Management and Future
DEFINITION OF SEVERE CHILDHOOD ASTHMA
DIAGNOSIS WORKUP EXPLORATIONS OF SEVERE ASTHMA IN CHILDREN
PATHOPHYSIOLOGY OF SEVERE ASTHMA IN CHILDREN
IMMUNE RESPONSE: DO PREFERENTIAL PATHWAYS LEAD TO THE SEVERITY OF ASTHMA?
REMODELING IN SEVERE CHILDHOOD ASTHMA
SEVERE ASTHMA PHENOTYPES IN CHILDREN
TREATMENT
SUMMARY
REFERENCES
Chapter 15. Challenges in Providing Preventive Care To Inner-City Children with Asthma
INTRODUCTION
CHALLENGES TO PREVENTIVE ASTHMA CARE
SUMMARY AND IMPLICATIONS
REFERENCES
Chapter 16. Pediatric Obesity and Asthma Quality of Life
BACKGROUND AND SIGNIFICANCE
REVIEW OF THE LITERATURE
STUDY BY THE AUTHOR
REFERENCES
Chapter 17. Asthma Action Plans and Self-Management: Beyond the Traffic Light
INTRODUCTION
ACTION PLANS
SELF-MANAGEMENT EDUCATION
HEALTH LITERACY-BASED ASTHMA EDUCATION
DISCUSSION
REFERENCES
Chapter 18. Work-Exacerbated Asthma
GENERAL PRINCIPLES
CASE DEFINITION OF WEA
PREVALENCE OF WEA
JOBS ASSOCIATED WITH WEA
WORK-RELATED RHINITIS AND WEA
PREVENTION AND MANAGEMENT
SUMMARY AND FUTURE RESEARCH
ACKNOWLEDGMENTS
REFERENCES
Chapter 19. Treating According to Asthma Control: Does it Work in Real Life?
WHAT IS CONTROL-BASED MANAGEMENT?
EVIDENCE ABOUT CONTROL-BASED MANAGEMENT IN REAL LIFE
STRENGTHS OF CONTROL-BASED MANAGEMENT IN REAL LIFE
LIMITATIONS OF CONTROL-BASED MANAGEMENT IN REAL LIFE
SUMMARY
ACKNOWLEDGMENTS
REFERENCES
Chapter 20. Occupational Asthma: New Deleterious Agents at the Workplace
INTRODUCTION
ALLERGIC OA
IIA
SUMMARY
REFERENCES
Chapter 21. Asthma and Obesity: The Dose Effect
ASTHMA
OBESITY
ASTHMA AND OBESITY
DOSE EFFECT
IMPLICATIONS
REFERENCES
Chapter 22. Why Otolaryngologists and Asthma Are a Good Match: The Allergic Rhinitis-Asthma Connection
INTRODUCTION
AR AND ASTHMA DEFINED
EPIDEMIOLOGY
PATHOPHYSIOLOGY
ASTHMA AND ATOPY
DIAGNOSIS
TREATMENT
SUMMARY
REFERENCES
Chapter 23. RADS and Its Variants: Asthma by Another Name
INTRODUCTION
CLINICAL VIGNETTE 1
ACUTE IRRITANT ASTHMA
CLINICAL VIGNETTE 2
ASTHMA FOLLOWING LOWER-LEVEL IRRITANT EXPOSURES
CLINICAL VIGNETTE 3
WORK-EXACERBATED ASTHMA
CHALLENGES IN THE DIAGNOSIS OF IRRITANT-INDUCED VERSUS IRRITANT-AGGRAVATED ASTHMA FROM AN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE PERSPECTIVE DISTINGUISHING WORKERS WITH PREEXISTING OR CONCURRENT ASTHMA FROM NEW-ONSET ASTHMA
SUMMARY
REFERENCES
Chapter 24. Asthma and Chronic Obstructive Pulmonary Disease: Similarities and Differences
INTRODUCTION
DEFINITIONS
CLINICAL FEATURES
GENETICS AND ENVIRONMENT
INFLAMMATION AND REMODELING
PHARMACOLOGIC RESPONSES
SUMMARY
REFERENCES
Chapter 25. The Overlap of Bronchiectasis and Immunodeficiency with Asthma
INTRODUCTION
REFERENCES
Back Cover

Systemvoraussetzungen

Als PDF speichern Als Link merken